The estimated Net Worth of Tolga Tanguler is at least $4.89 millió dollars as of 24 June 2024. Tolga Tanguler owns over 1,605 units of Alnylam Pharmaceuticals Inc stock worth over $3,053,871 and over the last 3 years Tolga sold ALNY stock worth over $1,840,439.
Tolga has made over 8 trades of the Alnylam Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Tolga sold 1,605 units of ALNY stock worth $370,755 on 24 June 2024.
The largest trade Tolga's ever made was exercising 5,026 units of Alnylam Pharmaceuticals Inc stock on 1 February 2022 worth over $1,316,360. On average, Tolga trades about 1,923 units every 79 days since 2022. As of 24 June 2024 Tolga still owns at least 11,660 units of Alnylam Pharmaceuticals Inc stock.
You can see the complete history of Tolga Tanguler stock trades at the bottom of the page.
Tolga's mailing address filed with the SEC is 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142.
Over the last 20 years, insiders at Alnylam Pharmaceuticals Inc have traded over $140,068,015 worth of Alnylam Pharmaceuticals Inc stock and bought 4,419,116 units worth $1,983,132,563 . The most active insiders traders include Sanofi, Christoph H Westphal és Kevin P Starr. On average, Alnylam Pharmaceuticals Inc executives and independent directors trade stock every 23 days with the average trade being worth of $11,181,724. The most recent stock trade was executed by Yvonne Greenstreet on 20 August 2024, trading 15,000 units of ALNY stock currently worth $1,275,000.
alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.
Alnylam Pharmaceuticals Inc executives and other stock owners filed with the SEC include: